The prevalence of hypertension is high and is increasing worldwide, whereas the proportion of controlled hypertension is low.
H
ypertension is a major public health challenge because of its high prevalence and associated cardiovascular disease and premature death (1, 2) . Randomized clinical trials have shown that pharmaceutical treatment and lifestyle modifications reduce blood pressure (BP) and risk for cardiovascular disease (3, 4) . Despite the proven effectiveness of these interventions, only 13.8% of adults with hypertension and 37.1% of patients with treated hypertension worldwide had their BP controlled in 2010 (1) . Barriers to hypertension control have been identified at the health care system, health care provider, and patient levels (5) . Such barriers include limited health care resources, lack of performance standards, and limited reimbursement for health coaching at the system level; lack of adherence to clinical guidelines at the provider level; and lack of adherence to prescribed medications and lifestyle modifications at the patient level (5) .
Implementation strategies to overcome the barriers to BP control, such as home BP monitoring, health coaching, provider training, and team-based care, have been tested in randomized trials (6, 7) . Most trials, however, have relatively small sample sizes and limited statistical power to reliably estimate intervention effects. Two previous reviews of implementation strategies for BP reduction included studies published up to 2003 and 2008 (6, 7) . They showed that, compared with usual care, many implementation strategies, including team change and home BP monitoring, significantly improved BP control (6, 7) . However, the effects of various implementation strategies on BP control were not directly compared in these meta-analyses. In addition, many implementation strategy trials have been published since 2008. In this meta-analysis, we aim to assess the comparative effectiveness of various implementation strategies on BP reduction in patients with hypertension by direct comparison. This information could be used by government and nongovernment organizations to select the most effective implementation strategies for hypertension control in communities.
tension" and "blood pressure" and an extensive list of terms related to provider education, team-based care, patient education, provider feedback and guideline adherence, and home BP monitoring (Supplement Tables  1 and 2 , available at Annals.org) (6 -9) . The search was restricted to clinical trials in human adults and had no language restrictions. Additional studies were identified by manual review of references cited in reviews, meta-analyses, and original articles. Finally, we searched ClinicalTrials.gov (September 2017), using the same terms as in the MEDLINE search, to find additional trials and assess publication bias by identifying completed trials without published results.
Study Selection
A study was eligible for inclusion if 1) it was a randomized controlled trial; 2) participants were adults with hypertension, defined as average systolic BP of at least 140 mm Hg, average diastolic BP of at least 90 mm Hg, or use of antihypertensive medication; 3) net change in systolic or diastolic BP was a main trial outcome; 4) the trial intervention targeted barriers to hypertension control at 1 or more of the patient, provider, and health care system levels; 5) the control group received usual care or minimal education; 6) the trial lasted at least 6 months; 7) variance of BP changes (or data to calculate it) was reported; and 8) clustering was accounted for in the analysis if the trial was cluster randomized. Two investigators independently screened abstracts for initial eligibility and reviewed full texts of eligible studies. Disagreements were resolved by consensus.
Data Extraction and Quality Assessment
Two investigators independently extracted data using a standardized form. Extracted data included study design, participant characteristics, intervention descriptions, and study results. Data from the 2 investigators were compared, and discrepancies were resolved by consensus. For trials reporting results at more than 1 time point, the report closest to the end of the intervention was selected.
Trials were divided into 8 implementation strategy categories based on intervention descriptions ( Table  1) . Categories were created on the basis of prior literature and availability of trials meeting our inclusion criteria (6, 7) . Two categories address only patient-level barriers to BP control: health coaching and home BP monitoring; 3 categories target only provider-level barriers: provider training, audit and feedback, and electronic decision-support systems; and 3 categories are multilevel strategies: multilevel strategies without teambased care, team-based care with physicians titrating medications, and team-based care with nonphysician providers titrating medications.
Health coaching strategies could be delivered in person or by telephone at several individual or group sessions during the intervention. The strategies were patient-centered, with a component of behavioral selfmonitoring. A health coach (case manager, nurse, medical assistant, or community health worker) and patients worked together using self-discovery or active learning processes to improve medication adherence and lifestyle modification (10) . Provider-level strategies aimed to improve the BP management performance of health care professionals primarily responsible for hypertensive patient care. Multilevel implementation strategies were aimed at overcoming barriers to hypertension control at 2 or more levels among patients, providers, health care systems, and communities. Team-based We included trials if their control groups were either usual care or minimal education. Usual care was defined as hypertension management by patients' normal care providers with no trial intervention. Minimal education included the provision of educational materials or a brief educational session to either patients or providers.
To assess quality, we modified the Cochrane Risk of Bias Tool to make it applicable to cluster trials in implementation research (13) . We focused on the following domains: random sequence generation, objective outcome assessment (blinding of BP observers or use of automatic BP cuffs), incomplete outcome data, and selective outcome reporting. Participant recruitment bias was also considered for cluster randomized trials, and funding sources were recorded for all trials. Two reviewers independently assessed risk of bias at the trial level.
Data Synthesis and Analysis
The Supplemental Methods section of the Supplement (available at Annals.org) describes the analysis and sample code in detail. For each trial, the net change in mean BP and associated SE were calculated from available data and defined as the difference (intervention minus control) in the changes of mean values (follow-up minus baseline). If BP was measured at several time points during follow-up, the measurements taken closest to the end of the intervention were used. In addition, the changes in mean BP and associated SEs in each randomized group were calculated separately for comparing effects among implementation strategies.
Random-effects models using the Sidik-Jonkman residual heterogeneity estimator with the KnappHartung small-sample adjustment were used to calculate pooled mean differences within implementation categories using inverse variance weighting (14 -16) . In some trials, several intervention groups were compared with the same reference group. In these cases, robust variance estimation was used to account for nonindependent estimates (17) . Heterogeneity was evaluated using the Cochran Q test and quantified with the I 2 index, and the 95% CI was calculated using the test-based method (18) . Publication bias was assessed using the Begg rank correlation test and the Egger weighted linear regression test for implementation strategies with at least 10 studies because of low statistical power with small sample sizes. When possible publication bias was observed, the trim-and-fill method was used to estimate the number of missing studies not published, augment the data to make the funnel plot more symmetrical, and calculate a summary estimate based on the augmented data (19) .
Generalized estimating equations (with an exchangeable correlation matrix between estimates within a study) were used to compare BP reductions associated with each implementation strategy after important covariate adjustment and for pairwise comparisons between implementation strategies. Indicator variables were used for each implementation strategy category, with the common control group as the reference. Weights for these models were exported from a random-effects meta-analysis, including all changes in mean BP and associated SEs from all treatment groups. As such, these weights take into account within-and between-trial variance. Each trial was treated as a cluster to maintain randomized comparisons, and the following trial-level baseline characteristics were adjusted: logit-transformed proportion male, centered mean age, centered mean systolic BP, centered trial duration, and whether the control group was usual care or minimal education. A sensitivity analysis was done including only trials where all participants had uncontrolled hypertension at baseline.
Analyses were done using packages metafor, robumeta, and forestplot in R, version 3.3.2 (R Project for Statistical Computing), and PROC GENMOD in SAS, version 9.4 (SAS Institute).
Role of the Funding Source
This work was supported in part by the National Institute of General Medical Sciences and the National Heart, Lung, and Blood Institute. The funding sources had no role in the design, conduct, or reporting of the study or the decision to publish the manuscript.
RESULTS
After duplicates were excluded, our search strategy identified 6697 references, of which 958 underwent full-text review ( Figure 1 ). In total, we included 100 articles reporting 121 comparisons with 55 920 participants (Supplement Table 3 , available at Annals.org). The median of the study-specific mean ages was 60 years (range, 33 to 77 years), and the medians of the study-specific mean systolic and diastolic BPs at baseline were 148 mm Hg (range, 124 to 190 mm Hg) and 86 mm Hg (range, 70 to 105 mm Hg), respectively. Trial durations ranged from 6 months to 5 years (median, 6 months). The number of comparisons per implementation category ranged from 39 for health coaching to 2 for audit and feedback ( Table 2) . We identified no trials at high risk of bias for random sequence generation; some were considered to have high risk of bias for objective outcome assessment (n = 3), incomplete outcome data (n = 13), selective reporting (n = 2), or re-cruitment bias (n = 1) (Supplement Tables 4 and 5 , available at Annals.org). Of the 88 studies reporting funding information, 17% received full or partial funding from pharmaceutical firms. The rest were funded by federal, state, and local governments; foundations; and universities.
The search of ClinicalTrials.gov identified 31 eligible trials. Of these, 8 of 9 published trials had been identified in our other searches, 19 were either ongoing or recently completed (defined as date of data collection completion for the primary outcome within the past 2 years), and 3 (1 of home BP monitoring and 2 of health coaching) with data collection completed more than 2 years ago were not published.
Effects of Implementation Strategies
All 5 patient-level and multilevel implementation strategies were associated with reductions in systolic BP (Supplement Figure 1 , available at Annals.org). Health coaching reduced systolic BP by 4.3 mm Hg (95% CI, 2.6 to 5.9 mm Hg) (P < 0.001), and home BP monitoring reduced it by 2.2 mm Hg (CI, 1.0 to 3.5 mm Hg) (P = 0.001). The multilevel strategies without teambased care reduced systolic BP by 3.9 mm Hg (CI, 1.3 to 6.5 mm Hg) (P = 0.003). Team-based care with physicians and nonphysician providers titrating medications had the largest reductions in pooled mean systolic BP of 5.7 mm Hg (CI, 3.6 to 7.9 mm Hg) (P < 0.001) and 6.6 mm Hg (CI, 4.2 to 9.0 mm Hg) (P < 0.001), respectively. Strategies targeting provider-level barriers to BP control did not statistically significantly reduce BP compared with the control group. Some evidence of publication bias was observed for health coaching (Egger P = 0.27; Begg P = 0.051) and team-based care with physicians titrating medications (Egger P = 0.146; Begg P = 0.020). However, trim-and-fill analysis showed that publication bias did not account for the observed associations for health coaching (change, Ϫ4.3 mm Hg [CI, Ϫ6.1 to Ϫ2.6 mm Hg]; P < 0.001) or for team-based care with physicians titrating medications (change, Ϫ4.2 mm Hg [CI, Ϫ6.5 to Ϫ1.8 mm Hg]; P < 0.001). Results were similar for diastolic BP (Supplement Figure 2 , available at Annals.org). Significant reductions in diastolic BP compared with the control group were seen for health coaching (change, Ϫ1.9 mm Hg [CI, Ϫ2.8 to Ϫ1.0 mm Hg]; P < 0.001), home BP monitoring (Ϫ1.5 mm Hg [CI, Ϫ2.0 to Ϫ1.0 mm Hg]; P < 0.001), team-based care with titration by a physician (Ϫ2.5 mm Hg [CI, Ϫ3.9 to Ϫ1.1 mm Hg]; P = 0.002), and team-based care with medication titration by a nonphysician provider (Ϫ3.5 mm Hg [CI, Ϫ4.6 to Ϫ2.5 mm Hg]; P < 0.001). Multilevel strategies without teambased care were not associated with a significant diastolic BP reduction (change, Ϫ2.7 mm Hg [CI, Ϫ6.0 to 0.6 mm Hg]; P = 0.114). Provider training, audit and feedback, and electronic decision-support systems were also not associated with significant reductions in diastolic BP.
Comparative Effectiveness of Implementation Strategies
After adjustment for important covariates and all implementation strategies simultaneously using generalized estimating equations, the 3 multilevel strategies were the most effective for reducing systolic BP ( Figure  2) . Team-based care with medication titration by a nonphysician had the greatest reduction in systolic BP Figure 3 , available at Annals.org). Insufficient studies met this criterion to estimate summary effects for audit and feedback and provider training. Figure 3 provides a pairwise comparison of the intervention strategies, ordered by effect sizes of systolic BP reduction and adjusted for covariates. Team-based care with titration by a nonphysician resulted in greater systolic BP reductions (range, Ϫ3.22 to Ϫ6.29 mm Hg) than any patient-level or provider-level strategy and greater diastolic BP reductions (range, Ϫ1.60 to Ϫ2.52 mm Hg) than home BP monitoring or any provider-level strategy. Team-based care with titration by a physician also resulted in greater reductions in systolic BP compared with all patient-level and provider-level strategies except health coaching.
Pairwise Comparison of Implementation Strategies

DISCUSSION
Our findings indicate that implementation strategies targeting multilevel or patient-level barriers are effective for BP reduction. Specifically, team-based care with and without a nonphysician team member titrating medications and multilevel strategies without teambased care were the most effective implementation strategies for hypertension control. Patient health coaching and home BP monitoring were also effective.
These findings have important public health implications. Despite strong evidence that antihypertensive medications and lifestyle modifications reduce BP and subsequent morbidity and mortality from cardiovascular disease, hypertension control rates are low worldwide (5) . The National Academy of Medicine and the National Heart, Lung, and Blood Institute have both called for research focusing on integrating evidencebased strategies into routine health care for hypertension control (20, 21) . Our findings provide evidence that multilevel, multicomponent implementation strategies are most useful and should be recommended in clinical practice and public health policy for hypertension control in communities. Two previous meta-analyses of intervention strategies for BP reduction reviewed studies published up to 2003 and 2008 and showed that some implementation strategies, including team-based care and home BP monitoring, improved hypertension control compared with the control group (6, 7). Between February 2008 and September 2017 (MEDLINE search), meta-analyses for some individual strategies have been published (8, (22) (23) (24) (25) , but none that included all implementation strategies for BP control. Our study expanded on the previous meta-analyses by including many trials published since 2008. Moreover, our meta-analysis is the first to our knowledge to directly compare the effect of various implementation strategies on BP control after adjustment for key trial and participant characteristics. Generalized estimating equations using studies as clusters allowed intervention strategies to be compared while preserving individual study randomization.
Team-based care strategies, in which hypertension management responsibilities are shared among team members (nurses, pharmacists, medical assistants, or community health workers) in addition to primary care physicians, were found to be most effective for BP control in our analyses. Santschi and colleagues reported that compared with usual care, pharmacist-led interventions showed greater reductions in systolic BP (change, Ϫ7.6 mm Hg [CI, Ϫ6.3 to Ϫ9.0 mm Hg]) and diastolic BP (Ϫ3.9 mm Hg [CI, Ϫ2.8 to Ϫ5.1 mm Hg]) in a meta-analysis of randomized controlled trials (22) . In addition, Clark and colleagues reported that compared with usual care, nurse-led interventions with a nurse prescribing medications showed greater reductions in systolic BP (change, Ϫ8.9 mm Hg [CI, Ϫ5.3 to Ϫ12.5 mm Hg]) and diastolic BP (Ϫ4.0 mm Hg [CI, Ϫ2.7 to Ϫ5.3 mm Hg]) in a meta-analysis of 4 trials (23). Teambased care is particularly effective because it frees physicians to focus on urgent and complex cases while allowing patient-centered care that is tailored, frequent, and collaborative (26) . Taken together, our findings and those from previous research provide strong evidence that team-based care is effective for BP control in hypertensive patients (24, 26, 27) .
Among the included trials reporting positive findings, pharmacist-led team-based care often included Mean net reductions were estimated using generalized estimating equations and adjusted for sex, age, baseline systolic (or diastolic) BP, trial duration, type of control group, and all other intervention strategies. Boxes are weighted by sample size. BP = blood pressure.
provider training, health coaching, and home BP monitoring in addition to task-sharing by pharmacists (28 -33) . Likewise, nurse-led team-based care usually included health coaching and home BP monitoring (34, 35) . Team-based strategies led by community health workers typically included health coaching, home BP monitoring, and provider training (36) . Multilevel implementation strategies without team-base care commonly consisted of health coaching, home BP monitoring, and provider training (37, 38) . In some multilevel intervention trials, pharmacists did medication titration, health coaching, and home BP monitoring independent of the primary care team (39) . Multilevel, multicomponent strategies combining team-based care, health coaching, home BP monitoring, and provider training are clearly the most effective for BP control among patients with hypertension.
Our findings also showed that health coaching and home BP monitoring alone resulted in significant BP reduction among hypertensive patients. Health coaching is effective for behavioral change, including lifestyle modification and antihypertensive medication adherence (40) . Especially when combined with home BP monitoring, it may therefore be an effective alternative for BP control in settings where multilevel strategies are not feasible because resources are limited. Future studies testing whether health coaching plus home BP monitoring provides a cost-effective approach could help inform BP control strategies in populations with health disparities.
A few trials tested strategies targeting only physician-level barriers to hypertension control (that is, provider training, audit and feedback, and electronic decision-support systems), and only the electronic decision-support systems strategy was significantly associated with BP reduction after multivariate adjustment, despite contributing only 4 trials to the analysis. Although the effects of provider-level strategies were limited on their own, they were commonly part of multilevel, multicomponent strategies shown to be effective. For example, Veterans Affairs medical centers and Kaiser Permanente have seen improvements in BP control among their patients after adopting multilevel strategies that included audit and feedback and electronic decision-support systems (41) (42) (43) . Because of the limited number of trials available in this category, the positive findings for electronic decision-support systems after adjustment, and the effective use of these interventions as part of multicomponent interventions, future clinical trials are needed to test additional physician-targeted implementation strategies (such as physician-patient communication), which could improve patient engagement and adherence to hypertension treatment (44, 45) .
Our analyses have several limitations. First, despite the inclusion of many trials in this meta-analysis, some implementation strategies did not have enough studies. For example, provider training, audit and feedback, electronic decision-support systems, and multilevel strategies without team-based care all had fewer than Adjusted for sex, age, baseline systolic BP (or diastolic BP), trial duration, and type of control group. Strategies are ordered by rankings of net reduction in mean systolic BP. Differences in BP reduction are located in the cell in common between the row-and column-defining implementation strategies. For the mean difference in systolic BP, the difference is the row strategy BP reduction minus the column strategy BP reduction. For the mean difference in diastolic BP, the difference is the column strategy minus the row strategy BP reduction. For example, the differences in mean systolic and diastolic BP reduction between team-based care with titration by a nonphysician and health coaching are Ϫ3.22 mm Hg (95% CI, Ϫ5.72 to Ϫ0.72 mm Hg) and Ϫ1.08 mm Hg (CI, Ϫ2.29 to 0.14 mm Hg), respectively. BP = blood pressure. † P < 0.050. ‡ P < 0.010. § P < 0.001.
10 comparisons. Second, few multilevel intervention trials addressed system-level barriers (that is, lack of performance standards, leadership commitment, and reimbursement of physician-patient health coaching). These factors could have a substantial effect on BP control among patients with hypertension and should be evaluated in future studies. Third, few clinical trials tested the effect of implementation strategies for free or low-cost medications or financial incentives on BP control. They did not meet our inclusion criteria and were not included in this meta-analysis. Fourth, an insufficient number of studies were done in subgroups of interest, such as patients with diabetes or chronic kidney disease, to estimate associations within these groups. Fifth, searches of ClinicalTrials.gov identified a few trials with data completion dates more than 2 years ago that were not yet published. Finally, only 20% of included trials were from low-and middle-income countries, where uncontrolled hypertension is a serious public health problem. However, many were done in low-income, ethnic minority, and other populations with health disparities in the United States and other high-income countries. Furthermore, 16 studies funded by the Global Alliance for Chronic Diseases will partially fill this knowledge gap (36, 46) . To translate these findings into routine clinical practice through scale-up and dissemination at the health care system level, additional research is needed on cost-effectiveness and sustainability of implementation strategies for BP control (20, 47) . Although some trials included in this meta-analysis did costeffectiveness analyses (30, 32, 33, 36, 37, 48 -52) , data were insufficient for a systematic review. In addition, no long-term follow-up studies after trial completion assessed intervention sustainability.
In conclusion, multilevel, multicomponent implementation strategies with and without team-based care are most effective for BP control among patients with hypertension. Health coaching and home BP monitoring that target barriers at the patient level are also effective. These strategies should be disseminated and scaled up in clinical practices and public health programs to improve hypertension control in communities. 
